Steven Cohen's position in Janux Therapeutics is currently worth $15.9 Million. That's 0.05% of their equity portfolio (380th largest holding). The investor owns 1.05% of the outstanding Janux Therapeutics stock. The investor's estimated purchase price is $29.4 Million, resulting in a loss of 46%.